Literature DB >> 29764781

EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined?

Romain Kania1, Benjamin Vérillaud1, Domitille Camous1, Charlotte Hautefort1, Thomas Somers2, Jérôme Waterval3, Sébastien Froelich4, Philippe Herman1.   

Abstract

The relevance of defining the growth of vestibular schwannoma (VS) is that any significant VS growth may impact treatment strategy. A conservative treatment strategy is often proposed as a primary treatment option in the management of VS. Several authors have demonstrated that a significant proportion of VSs do not grow, and those that do, usually grow slowly. Surgical and/or radiosurgical treatment options may be offered to the patient according to the VS growth. Therefore, defining the VS growth is a determinant in managing treatment strategies. A comprehensive literature search was performed to examine the definition of tumor growth for VS. The literature review was conducted using PubMed and Embase databases dated back to 20 years (1995-2015) and was updated until February 2015. VS growth should be measured on contrast-enhanced T1-weighted images. Although there the overall quality of the present studies is low, all highlight a significant VS growth of > 2 mm, and/or 1.2 cm3, and/or 20% change in volume, and/or the square of the product of the 2 orthogonal diameters. We suggest that VS growth should instead change management strategies when a 3-mm increase in diameter on two consecutive MRI scans are performed 1 year apart.

Entities:  

Mesh:

Year:  2018        PMID: 29764781      PMCID: PMC6354486          DOI: 10.5152/iao.2018.5360

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  41 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

2.  Conservative management of unilateral acoustic neuromas.

Authors:  D C Tschudi; T E Linder; U Fisch
Journal:  Am J Otol       Date:  2000-09

3.  Determinants of tumor size and growth in vestibular schwannomas.

Authors:  S L Nutik; M J Babb
Journal:  J Neurosurg       Date:  2001-06       Impact factor: 5.115

4.  Acoustic tumor growth: implications for treatment choices.

Authors:  M J Fucci; C A Buchman; D E Brackmann; K I Berliner
Journal:  Am J Otol       Date:  1999-07

5.  Investigations into the natural history of vestibular schwannomas.

Authors:  F Mirz; B Jørgensen; B Fiirgaard; E Lundorf; C B Pedersen
Journal:  Clin Otolaryngol Allied Sci       Date:  1999-02

6.  Update on conservative management of acoustic neuroma.

Authors:  D L Hoistad; G Melnik; B Mamikoglu; R Battista; C A O'Connor; R J Wiet
Journal:  Otol Neurotol       Date:  2001-09       Impact factor: 2.311

7.  Effectiveness of conservative management of acoustic neuromas.

Authors:  Y J Shin; B Fraysse; C Cognard; I Gafsi; J P Charlet; C Berges; O Deguine; M Tremoulet
Journal:  Am J Otol       Date:  2000-11

8.  The natural history of untreated vestibular schwannomas. Is there a role for conservative management?

Authors:  R M Walsh; A P Bath; M L Bance; A Keller; C H Tator; J A Rutka
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2000

Review 9.  Natural history of acoustic neuromas.

Authors:  S I Rosenberg
Journal:  Laryngoscope       Date:  2000-04       Impact factor: 3.325

10.  What is the best method for reporting tumor diameter in vestibular schwannoma?

Authors:  Yuichiro Tanaka; Kazuhiro Hongo; Tsuyoshi Tada; Shigeaki Kobayashi
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

View more
  2 in total

1.  A prediction model for recurrence after translabyrinthine surgery for vestibular schwannoma: toward personalized postoperative surveillance.

Authors:  Nick P de Boer; Stefan Böhringer; Radboud W Koot; Martijn J A Malessy; Andel G L van der Mey; Jeroen C Jansen; Erik F Hensen
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-12       Impact factor: 3.236

2.  Prognostic Factors for the Outcome of Translabyrinthine Surgery for Vestibular Schwannomas.

Authors:  Nick P de Boer; Radboud W Koot; Jeroen C Jansen; Stefan Böhringer; Jeroen A Crouzen; Andel G L van der Mey; Martijn J A Malessy; Erik F Hensen
Journal:  Otol Neurotol       Date:  2021-03-01       Impact factor: 2.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.